Corporate news

Grifols reinforces its commitment to research in the 7th edition of the Martín Villar Awards for Research on Hemostasis Created in 2007, the awards recognize progress made in the field of Hemostasis. The awards are endowed with 20,000 euros for each of the two prizes: basic research and clinical research.
+ info

Grifols acquires 50% of the share capital of Kiro Robotics for 21 million euros Grifols strengthens its commitment to research and promotes the international growth of its Hospital division
+ info

Grifols achieves ten years of research into Alzheimer's In the last decade the company has developed a comprehensive strategy for research into the disease, and currently has three clinical trials underway
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

New transfusion medicine solutions

Grifols is committed to helping you work efficiently to deliver blood that is safe and compatible for patients. + info


get to know us better